Favorable outcome in clinically stage II melanoma patients i…
Favorable outcome in clinically stage II melanoma patients is associated with the presence of activated tumor infiltrating T-lymphocytes and preserved MHC class I antigen expression.
Article, Chapter
Authors:
I.S. van Houdt
Publication:
Volume:123,
Issue:3,
Page(s):609-615
Published:
2008
We were unable to find direct full text links for this item.